Patient Perspectives on Solid Organ Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia.
Karen B VanterpoolKadiatou DialloEllie KimSarah E Van Pilsum RasmussenMorgan A JohnsonZachary PredmoreJanetta BrundageBrittany BarnabaNiraj M DesaiMacey L LevanHannah C SungOlivia S KatesJeremy SugarmanChristine M DurandPublished in: Open forum infectious diseases (2024)
Our findings suggest that HCV D+/R- kidney, liver, and heart and lung transplant recipients outside of clinical trials had overall positive experiences. However, HCV transmission risk, treatments costs, and treatment delays were a source of concern that might be mitigated with targeted pretransplant education.